Time for a Change? Making Treatment Decisions in Multiple Sclerosis (Transcript)

WebMD Global requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships with ineligible companies.

Disclosures for additional planners can be found here.

Faculty

Jiwon Oh, MD, PhD

Associate Professor
Division of Neurology
St Michael's Hospital, University of Toronto
Toronto, Canada

Disclosures

Jiwon Oh, MD, MD, PhD, has the following relevant financial relationships:
Consultant or advisor for: Biogen-Idec; Bristol Myers Squibb; EMD-Serono; Novartis; Roche; Sanofi-Genzyme
Speaker or member of speakers bureau for: Biogen-Idec; EMD-Serono; Novartis; Roche; Sanofi-Genzyme
Research funding from: Biogen-Idec; EMD-Serono; Roche

Editor

Leanne Fairley, BJ Hon

Medical Education Director, WebMD Global, LLC

Disclosures

Leanne Fairley, BJ Hon, has no relevant financial relationships.

Compliance Reviewer

Amanda Jett, PharmD, BCACP

Associate Director, Accreditation and Compliance

Disclosures

Amanda Jett, PharmD, BCACP, has no relevant financial relationships.